| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs868795 |
chr12:121371233-121371234 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
| 2 |
rs567580023 |
chr12:121371265-121371266 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 3 |
rs536633866 |
chr12:121371319-121371320 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs115968213 |
chr12:121371393-121371394 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs373726261 |
chr12:121371414-121371415 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 6 |
rs564822841 |
chr12:121371425-121371426 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs113308477 |
chr12:121371435-121371436 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs11065342 |
chr12:121371436-121371437 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 9 |
rs545283805 |
chr12:121371449-121371450 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 10 |
rs558628471 |
chr12:121371479-121371480 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs189333223 |
chr12:121371505-121371506 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs369174744 |
chr12:121371519-121371520 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs2701191 |
chr12:121371577-121371578 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs3999400 |
chr12:121371610-121371611 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs3999399 |
chr12:121371636-121371637 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs3999398 |
chr12:121371650-121371651 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs3999397 |
chr12:121371710-121371711 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs200192042 |
chr12:121371722-121371723 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs537965709 |
chr12:121371730-121371731 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs73224341 |
chr12:121371731-121371732 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 21 |
rs370823044 |
chr12:121371736-121371737 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs561024756 |
chr12:121371754-121371755 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs571205191 |
chr12:121371777-121371778 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs139740795 |
chr12:121371778-121371779 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs113931348 |
chr12:121371784-121371785 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs77620531 |
chr12:121371791-121371792 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs377269656 |
chr12:121371793-121371794 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs370015876 |
chr12:121371795-121371796 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs574417352 |
chr12:121371798-121371799 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs113532121 |
chr12:121371809-121371810 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs11065343 |
chr12:121371866-121371867 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 32 |
rs77350597 |
chr12:121371899-121371900 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs2004955 |
chr12:121371941-121371942 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs2004954 |
chr12:121371946-121371947 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs543429262 |
chr12:121371959-121371960 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs144852941 |
chr12:121371963-121371964 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs73224342 |
chr12:121372005-121372006 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 38 |
rs1106108 |
chr12:121372033-121372034 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs181670007 |
chr12:121372067-121372068 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs148593490 |
chr12:121372081-121372082 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs35883953 |
chr12:121372113-121372114 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs5801410 |
chr12:121372114-121372115 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs576773578 |
chr12:121372115-121372116 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs533398891 |
chr12:121372122-121372123 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs567763961 |
chr12:121372156-121372157 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs536302700 |
chr12:121372257-121372258 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs550158607 |
chr12:121372292-121372293 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs544992209 |
chr12:121372306-121372307 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs564972649 |
chr12:121372323-121372324 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs185934914 |
chr12:121372335-121372336 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|